AI in Healthcare White Paper

      This article was written by Amber Zhou and Kwon Sok Oh, Financial Analysts at I Know First.  

Highlights

Abstract Part One: Artificial Intelligence in Healthcare
  • Overview of AI in Healthcare
  • Debate on Whether AI would replace doctors
    • AI Could Replace Major Doctor Roles
    • Argument on AI Replacing Only Some Major Doctor Roles
    • Argument on AI Replacing All Major Doctor Roles
  • Obstacles of AI in Healthcare
Part Two Epidemics Forecasting
  • Epidemics Forecasting
  • Surveillance System from Internet-based Sources
    • Different Methods
    • Accuracy and Timeliness
  • Comparison with Weather Forecasting
    • Similarities
    • Differences
Conclusion

I Know First's Adaptation of AI in Healthcare

premiumRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content here

AI In Healthcare: Artificial Intelligence Can Heal The Healthcare Industry

  This article was written by Julia Masch, a Financial Analyst at I Know First.  



Summary

  • How Artificial Intelligence Can Be Used In Healthcare
  • Different Implementations of AI
  • I Know First Forays Into Predictive Healthcare

premiumRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content here

Press Release: I Know First Ventures Into Predictive Healthcare Realm

I Know First Ventures Into Predictive Healthcare Realm

Earlier today, I Know First had a meeting with KST Medical Group which has monumental potential for both companies. I Know First CEO Yaron Golgher met with KST Medical Chairman Chong Han at the I Know First Tel Aviv office to confirm the unprecedented partnership. I Know First was introduced to the Chinese pharmaceutical company by Mr. Basketball, Tal Brody, who is now helping I Know First build its presence in China. Together, the companies will work

Read More

Quick Win By The Algorithm: Arrowhead Pharmaceuticals, Inc. Reports Third Quarter 2017 Fiscal Results

Stock Prediction Quick Win

Read The Full Forecast

Dynavax Stock Analysis: Low Risk and High Reward, Buy Now.

  The article was written by Moises Meir, a Financial Analyst at I Know First

Dynavax Stock Analysis: Low Risk and High Reward, Buy Now.

Summary
  • Dynavax has an upcoming product that will revolutionize the vaccine industry./li>
  • When is HEPLISAV-B's launch?
  • Other current projects at DVAX
  • Financial/Stock Performance & I Know First's Bullish Forecast

Outlook For Gold PricesRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content Here

Quick Win By The Algorithm: DVAX Reaching New Heights

Quick Win by the Algorithm:

Read The Full Forecast

Quick win

Quick Win by the Algorithm: Biopharmaceutical Company IMMU a bullish winner

Quick Win By The Algorithm

Read The Full Forecast

quick win
Pages:1234»